z-logo
open-access-imgOpen Access
Multi-Omics Approach: New Potential Key Mechanisms Implicated in Cardiorenal Syndromes
Author(s) -
Grazia Maria Virzì,
Anna Clementi,
Giovanni Giorgio Battaglia,
Claudio Ronco
Publication year - 2019
Publication title -
cardiorenal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.661
H-Index - 21
eISSN - 1664-3828
pISSN - 1664-5502
DOI - 10.1159/000497748
Subject(s) - cardiorenal syndrome , crosstalk , medicine , bioinformatics , inflammation , proteomics , chemokine , acute kidney injury , pathogenesis , epigenetics , kidney , biology , immunology , gene , biochemistry , physics , optics
Cardiorenal syndromes (CRS) include a scenario of clinical interactions characterized by the heart and kidney dysfunction. The crosstalk between cardiac and renal systems is clearly evidenced but not completely understood. Multi-factorial mechanisms leading to CRS do not involve only hemodynamic parameters. In fact, in recent works on organ crosstalk endothelial injury, the alteration of normal immunologic balance, cell death, inflammatory cascades, cell adhesion molecules, cytokine and chemokine overexpression, neutrophil migration, leukocyte trafficking, caspase-mediated induction of apoptotic mechanisms and oxidative stress has been demonstrated to induce distant organ dysfunction. Furthermore, new alternative mechanisms using the multi-omics approach may be implicated in the pathogenesis of cardiorenal crosstalk. The study of “omics” modifications in the setting of cardiovascular and renal disease represents an emerging area of research. Over the last years, indeed, many studies have elucidated the exact mechanisms involved in gene expression and regulation, cellular communication and organ crosstalk. In this review, we analyze epigenetics, gene expression, small non-coding RNAs, extracellular vesicles, proteomics, and metabolomics in the setting of CRS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here